Osiecki M, Dądalski M, Oracz G, Kierkuś J. A clinical characteristic of paediatric ulcerative colitis patients qualified for a Cyclosporin A therapy. Pediatria Polska - Polish Journal of Paediatrics. 2017;92(4):378-381.
APA
Osiecki, M., Dądalski, M., Oracz, G., & Kierkuś, J. (2017). A clinical characteristic of paediatric ulcerative colitis patients qualified for a Cyclosporin A therapy. Pediatria Polska - Polish Journal of Paediatrics, 92(4), 378-381.
Chicago
Osiecki, Marcin, Maciej Dądalski, Grzegorz Oracz, and Jarosław Kierkuś. 2017. "A clinical characteristic of paediatric ulcerative colitis patients qualified for a Cyclosporin A therapy". Pediatria Polska - Polish Journal of Paediatrics 92 (4): 378-381.
Harvard
Osiecki, M., Dądalski, M., Oracz, G., and Kierkuś, J. (2017). A clinical characteristic of paediatric ulcerative colitis patients qualified for a Cyclosporin A therapy. Pediatria Polska - Polish Journal of Paediatrics, 92(4), pp.378-381.
MLA
Osiecki, Marcin et al. "A clinical characteristic of paediatric ulcerative colitis patients qualified for a Cyclosporin A therapy." Pediatria Polska - Polish Journal of Paediatrics, vol. 92, no. 4, 2017, pp. 378-381.
Vancouver
Osiecki M, Dądalski M, Oracz G, Kierkuś J. A clinical characteristic of paediatric ulcerative colitis patients qualified for a Cyclosporin A therapy. Pediatria Polska - Polish Journal of Paediatrics. 2017;92(4):378-381.